Management of von Willebrand Disease With a Factor VIII‐Poor von Willebrand Factor Concentrate: Results From the Paediatric Cohort of a Prospective Observational Post‐Marketing Study
This analysis enlarges clinical experience of an FVIII-poor pdVWF in the paediatric population. This concentrate offers safe and effective treatment regardless of VWD severity.
Authors
- Céline Henriet (ORCID: https://orcid.org/0000-0002-7796-1569)
- Yohann Repessé (ORCID: https://orcid.org/0000-0003-3809-3858)
- S. Claeyssens (ORCID: https://orcid.org/0000-0002-4440-9313)
- Hérvè Chambost (ORCID: https://orcid.org/0000-0002-5319-1969)
- Sophie Susen (ORCID: https://orcid.org/0000-0001-5953-163X)
- Sandrine Meunier (ORCID: https://orcid.org/0000-0001-6785-4332)
- Guillaume Mourey (ORCID: https://orcid.org/0000-0002-9772-9898)
- Annie Harroche (ORCID: https://orcid.org/0000-0001-7368-4624)
- Jenny Goudemand (ORCID: https://orcid.org/0000-0003-3019-3299)
- Annie Borel‐Derlon
- Thierry Leroi
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Lille’s Cardiology Hospital (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Haemophilia Foundation Australia (AU)
- LFB (France) (FR)
- Hôpital Louis Pradel (FR)
- Hôpital Purpan (FR)
- Hôpital de la Timone (FR)
- Université Marie et Louis Pasteur (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- Haemophilia
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1111/hae.70129
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00